Skip to main content

Table 1 The clinical characteristics and variants of 12 OTCD patients

From: Clinical and biochemical characteristics of patients with ornithine transcarbamylase deficiency and in silico analysis of OTC gene

Patient NO.

Gender

Age at diagnosis

Type

Clinlcal symptom

OTC Variant Amino acid changes

Clinlcal outcomes

01

M

1D

EO

Hyperammonemia, Hypotonia, Convulsion, Dyspnea

c.512 A > G p.Q171R

Death

02

M

1D

EO

Hyperammonemia, Coma, Hypotonia

c.867 + 1 G > C

Death

03

M

7D

EO

Vomit, Hypotonia, Convulsion, Dyspnea, Coma

c. 782T > C p. I261T

Death

04

F

2Y

LO

Abnormal liver function, Vomit

c.103insA p.V35SerfsX7

Death

05

M

2D

EO

Convulsion, Coma, Dyspnea

c.274 C > T p.R92R*

Death

06

M

2Y6M

AS

Asymptomatic

c.119G > A p.R40H

Alive

07

F

12Y

LO

Dystropy, Breathing attack

c.968T > G p.V323G

Alive

08

M

8D

EO

Hyperammonemia, Metabolic disorder

c. 959G > C p. R320P

Missing

09

M

1 M

EO

Hyperammonemia, Metabolic disorder

c.717 + 1G > T

Alive

10

M

5D

EO

Hyperammonemia, Cyanosis

c.674 C > T p.P225L

Death

11

M

1D

EO

Family history, Hyperammonemia

c.143T > C p.F48S

Death

12

M

3D

EO

Hyperammonemia, Vomit, Coma

c.421 C > T p.R141*

Death

  1. M, Male; F, Female; D, days; M, months; Y, years; EO, early-onset; LO, late-onset; AS, Asymptomatic.“” donates novel mutation